4-butyrolactone has been researched along with palinurin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro, A; Fall, Y; Gómez, G; Martínez, A; Pérez, DI; Pérez, M | 1 |
| Caron, G; Ermondi, G; Fall, Y; Gándara, Z; Gerbaldo, M; Gómez, G; Martínez, A; Pérez, DI; Pérez, M; Pintos, IG | 1 |
| Alonso, D; Bidon-Chanal, A; Fuertes, A; Luque, FJ; Martínez, A; Medina, M; Pérez, DI | 1 |
3 other study(ies) available for 4-butyrolactone and palinurin
| Article | Year |
|---|---|
The first enantioselective synthesis of palinurin.
Topics: 4-Butyrolactone; Aldehydes; Furans; Phosphines; Propionates; Stereoisomerism; Substrate Specificity; Terpenes | 2009 |
An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors.
Topics: 4-Butyrolactone; Alzheimer Disease; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Models, Biological; Models, Molecular; Quantitative Structure-Activity Relationship; Software; Stereoisomerism | 2011 |
Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.
Topics: 4-Butyrolactone; Allosteric Regulation; Animals; Binding Sites; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Protein Kinase Inhibitors; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 2013 |